According to Incyte's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.9789. At the end of 2022 the company had a P/E ratio of 52.2.
Year | P/E ratio | Change |
---|---|---|
2022 | 52.2 | 204.83% |
2021 | 17.1 | -127.34% |
2020 | -62.6 | -249.06% |
2019 | 42.0 | -65.67% |
2018 | 122 | -301.43% |
2017 | -60.7 | -133.91% |
2016 | 179 | -96.7% |
2015 | > 1000 | -2325.07% |
2014 | -244 | 159.92% |
2013 | -93.8 | 103.21% |
2012 | -46.1 | 354.93% |
2011 | -10.1 | -84.08% |
2010 | -63.7 | 1340.24% |
2009 | -4.42 | 131.03% |
2008 | -1.91 | -80.38% |
2007 | -9.76 | 48.7% |
2006 | -6.56 | 51.14% |
2005 | -4.34 | -3.96% |
2004 | -4.52 | 54.64% |
2003 | -2.92 | 30.13% |
2002 | -2.25 | -67.99% |
2001 | -7.02 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.